Bill 118 s 4667, also known as the Risky Research Review Act, is a piece of legislation currently being considered by the US Congress. The main purpose of this bill is to establish a framework for the review and oversight of ...
federally funded research projects that involve significant risks to human subjects.
Under the provisions of the Risky Research Review Act, any research project that is deemed to involve risks that are greater than those typically encountered in everyday life would be subject to additional scrutiny and oversight. This would include projects that involve experimental treatments, invasive procedures, or other potentially harmful interventions.
The bill outlines specific criteria for determining which research projects would be considered "risky" and therefore subject to review. It also establishes a new oversight body, the Risky Research Review Board, which would be responsible for evaluating and approving these projects.
Proponents of the bill argue that it is necessary to ensure the safety and well-being of human subjects involved in research projects, particularly those that involve significant risks. They believe that the establishment of clear guidelines and oversight mechanisms will help to prevent unethical or dangerous research practices.
Opponents of the bill, however, raise concerns about the potential for increased bureaucracy and delays in the research process. They argue that the additional oversight requirements could stifle innovation and hinder scientific progress.
Overall, the Risky Research Review Act represents an important step towards ensuring the ethical conduct of research involving human subjects. It will be interesting to see how this legislation progresses through the legislative process and what impact it may have on the field of research in the United States.